With the launch of a new West Yorkshire healthy heart hypertension guideline coming soon, this blog comes from Emily Turner, a lead pharmacist with a specialist interest in cardio renal. Emily’s blog looks at how the new guideline is an opportunity for West Yorkshire to lead on prevention.
Hello, my name is Emily
High blood pressure (also called hypertension) is the biggest risk factor for heart disease and stroke that we can do something about. Around one in four adults in the UK have it, but many remain undiagnosed or undertreated. In West Yorkshire, this adds up to thousands of preventable heart attacks, strokes and cases of kidney disease every year.
The new West Yorkshire healthy heart hypertension guideline gives us the chance to change this - and to do so together.
A stronger evidence base, a sharper focus
The evidence is clear - controlling blood pressure saves lives. Lowering it, even by a small amount, reduces the risk of heart attacks, strokes and early death. The new guideline encourages more ambitious blood pressure targets (below 130 over 80), provided treatment is well tolerated, reflecting evidence that lowering systolic blood pressure further reduces risk. Aiming lower is expected to get more people to the NICE targets overall.
A key change is the move towards using two types of blood pressure medicines together, right from the start, but at lower doses. This approach helps people reach healthier blood pressure levels more quickly and safely, with fewer side effects. It also avoids the stop-start cycle of switching medicines over time and reduces the need for repeated trips to the doctor.
Read more on the Partnership website.
Thanks for reading,
Emily